AstraZeneca, Isis Pharmaceuticals to Collaborate to Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases

By: via Benzinga
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and AstraZeneca (NYSE: AZN) today announced a strategic collaboration to discover and develop ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.